Member Info for SuperStockMan

His update in feb 2020 was 4momths late so this is lightning fast for AC. Will be glad when he is finally off the listed holders

Wish I had your confidence group. Seems to me its a bit of a gamble on whether we will get positive near term news to spur price action, it would have to be material to shift gears with DT and AC still selling with the placing subscribers. I've written this off until later this year, hope you're right and this moves north before then

Miserable end to a miserable day, nfx never fails to surprise me, I was actually looking forward to this update, what a fool I am. Not sold but have lost patience and faith, only holding on to see what comes about from Anne in the next quarter, my loss is so large now I might as well see it to the end, hopefully this is a turning point.

Better now than later, hopefully should be rid of them both this year at some point

Ye I spotted that a few months ago, someone needs to call the LinkedIn police

Some great news released today, it's made me feel more secure that sustaining my significantly overweight position will pay off in the long run. Hopefully this stands us in good stead for the grant and if we get some near term revenue from Oxillio, ebers or vistagen this would be great start to repairing some of the faith lost by some. Would also have the added benefit of encouraging some more tr1s from DT and AC at a quicker pace. Ps: good post UQ

They're valid points Abman but I agree with Soup silence is better than false promises, what we need now is delivery 1st; complemented by hearing from the new CEO. At this stage re-outlining the strategy or vision on an interview for PR purposes would be falling into the same trap we had with DG who was too willing to update the market for better or worse. The strategy is unlikely to have changed since CB had his interview and as such it would unnecessarily highlight the issue of how little has been achieved to commercialize the business. I appreciate for some this would be reassuring and may even temporarily spur upward movement in SP, but it would be more of the same and immaterial to the sort of shareholders you want to attract.

To be fair pessimism is as important as optimism when investing, with nfx in particular with the year we've had I cant blame anyone for a healthy dose of skepticism. Myself, im happy with the appointments in the last few weeks, but tend to agree that the odds of a material deal being announced before xmas are relatively low, I hope I'm proved wrong. Talks this morning about NED for beancounting before a deal could be true but it could also be true they've been brought in early to help with those undisclosed payments that will shortly require clarifying with the market when they publish the half year results.

I'm confused by the assumptions to be honest, if you are ****ed about performance or the dramas this year, surely that anger should be placed at people with direct responsibility for it I.e. DT, DG, and CB. Not a consultant that does contract work for investor relations and a NED that has not been paid and incentivised by warrants that cant be used because performance has been so poor. How have you formulated that opinion Offshore and why are a few others so ready to agree, where is this info that makes you so ready to point the finger? Is it by any chance the knowledge that if the cause of this is CB then we have issues with the hope of performance moving forward? Or is it a blinding allegiance to DG? And I am completely confused by anyone that thinks DT is somehow a victim and bears no responsibility. I think some of you have misplaced your anger.

Dont believe anyone could answer this other than CB himself. Not sure if he had any involvement on the oxilio deal or vistagen, it's not like they would publish who was responsible. Nor would we know what he maybe currently lining up in future pipeline. What you can say is that he is part time non exec that has not been paid other than via timed excersisable warrants for his work which are currently 2-3 times more expensive than market value at present. I dont think it's fair to single him out

Agree with most observations made today, I am after all still holding for a reason. However why is Jullian Higgins holding not on the nuformix website, appreciate that doesn't say much as it's been wholly inaccurate most of the year and only recently updated to include CPI, DT and AC with all 3 still lowering their holdings. But saying that can clearly see the rns from may last year and no update since so he must still hold, would have thought when they updated this they would have included him unless it was just a knee jerk reaction in october as all 3 TR1s needed to be issued. One thing is clear though the company doesn't place much care in its investor relations activities

I would add that I am as irritated as anyone with performance this year, but my main grievance is the board shenanigans that have occured, in addition to lack of published progress on other agreements. Obviously I want them to progress nxp002 but am prepared to wait for it if required

To add to this do remember this deal is transformative and includes many years of development work. It stands to reason that they will want to ensure negotiations are as lucrative as possible, if that means abandoning a prior negotiation position as the market has changed during discussions, or approaching other partners because they're not getting what they want. I would expect them to have moved goal posts this year, it would be idiotic not to do so. This would likely cause a delay and potentially couldve upset the partner in original discussions, who knows. I know if it was me in the negotiating seat I would take my time to achieve the result I wanted as this deal ; whilst regional in nature, it will potentially set a precedent for other partners interested in the product in other regions after the publication of any agreement.

lol sorry whimax, re-read your post and now mine seems pointless =p

Why Whimax? = the guy is selling is still selling his holding, he sold a shed load last Oct/Nov Passing Date on which the threshold was crossed or reached 18/11/2019 then; Date on which issuer notified 10/02/2020 and then us mugs find out 12 February 2020. What also got released during this period? = 25/10/19 - The infamous Times article here it is for those that forgot:

= Shares in Nuformix (NFX) gave up recent gains yesterday to trade 5% lower and close at 8¼p. Chatter that Nuformix is close to securing a licensing deal with Kissei Pharmaceutical, one of Japan’s largest drug companies, has sent shares in the minnow higher in recent days. Market gossip suggests that Kissei is in talks to license Nuformix’s lead fibrosis treatment alongside its unique oral delivery system. The proprietary delivery mechanism resolves a number of efficacy problems that have plagued Kissei for years, they claim. The partnership could enable Kissei to treat other conditions. The reports suggest that the deal being discussed involves an upfront milestone payment of £15 million and annual royalty payments worth more than £200 million. If a deal is struck and structured on those terms, Nuformix would generate revenues well in excess of its current £40 million market value.

Even if this was completely innocent, the mere suspicion it potentially generates in my view the guy should no longer be a director of a Nuformix 100% owned subsidiary, and this should have occurred in Feb.
Coincidence that this topic was discussed on the boards at the time of his most recent TR1 last week and he was an active member of the subsidiary and now this week he is not?

52,862,941 = total amount of AC and DT shares remaining combined. I think judging by their activity over the last 12months it would be reasonable to assume they plan to completely dispose of all their holdings. Will be glad when they're gone yes, do have to wonder why? is it out of spite? is it due to an agreement? or is it because they hold no faith in the company to produce value to SH?. We can only guess as we still don't the reason for DT dismissal, and the suspicious last clearance of AC's holding timed perfectly to coincide with a leaked unsubstantiated news article to a certain tabloid and subsequent severe late reporting of such activity until after DT had vacated the premises as prior chairman, all maybe a coincidence, or maybe not as we don't know as we don't what the drama has been at board level in the last 12months, either way the late reporting was poor. Add into the equation CPI, which i am naturally less suspicious/concerned with however doesn't help things for us poor suffering LTH as they clear in combination with the other 2, i do suspect CPI will be done more at a reasonable pace, but all 3 TR1's in the last week is a bit of a bitter pill, is it not? add CPI to collective we suspect will be sold in future and we have a grand total of 82,575,882 left to clear. Doesn't look like we will do well without transformational news does it? think we will ever see 1 of these issued that actually has someone accumulating?

Hi Soup, was wondering where you see Alan as a board member- I only saw CB, KK, JH and Roger Jones as active members.
NUFORMIX PLC
Company number 09632100

But can now see he's registered on
NUFORMIX TECHNOLOGIES LIMITED
Company number 06407331

Agree that activity was suspicious and in my view warrants investigation from relevant authorities.
if it wasn't for the murkiness of the on goings with DT and AC i would be far more confident in this company and further building my position, this was and remains my largest red flag with them.

latest RNS cant really be called anything but what it is, total carp. Placement at these levels, irrespective of the limited amount, is poor. Sentiment at its lowest, and they're pleased to announce a placement with little to no new information provided on any of the development activities. Can only hope that as some has said this marks a turning point for what has been a terrible year in general and nfx's progress. I do now begin to feel like an idiot having bought these from 12p, 9p and 4p respectively. Excited by the tech, disappointed by the board shenanigans and lack of meaningful progress. I'm willing to cut them slack in the sense that there is a low headcount and Joanne is still hopefully hard at work, but would be great to see some shares purchased by 2 of the board members so we can be assured their interest aligns with ours. Would also be nice to see anything other than Nominee accounts on the holdings listed (aside from DG and JH). Here's hoping for a turnaround for us all, the Oxilio was a step in the right direction let's hope more progress follows.

Staying clear of the Politics and back to NFX, a lot of assumptions on Dan's departure. Thoughts from various posters believe either he left on his own accord or was pushed. Either could be true, fact is we don't know; but I would like to suggest a third with no information to back this up and this is complete conjecture on my part, perhaps his move to Qureight was planned and agreed with NFX, we know Dan has always been interested in Ai as a means to improve drug development and targeting unmet needs in particular with Fibrotic conditions we also know that Qureight is local to NFX and has been founded by one of our key advisory board members Dr Muhunthan Thillai, interestingly enough they're also targeting research in the same area as 2 of our lead drug candidates. Could be coincidence or potentially we're planting seeds that may bear their fruits in future, who knows.

I can see my wording may have not been clear, whilst I find it irritating losing track of DT's holding, assuming he has transferred to a nominee account. I am perplexed by the CPI holding not being listed, surely they have not transferred there's to a nominee account?